Current Section


COVID-19 Vaccine Tracker
Returning to Normalcy

Stay in the know

WEEK OF 3/1/2021

This weekly tracker shows key metrics covering the spread of COVID-19 and the progress of the vaccination. An analysis of the data estimates a return to normalcy in the second quarter potentially.

Many Reasons for Optimism in the U.S.

ADMINISTERED DOSES ACCELERATING
What Is the Limit?

administered doses accelerating-what is the limit?

TAKE AWAY:

Doses allocated to states are surging and will be administered soon, helping trend vaccinations recover.

Note: Takes current trend since January 1, extrapolates forward, and cuts off at noted per day administered doses

HERD IMMUNITY BY Late Q2?
Vulnerable Population Vaccination Rates

herd immunity by q2? - vulnerable population vaccine rates

Take Away:

While delays due to winter storms pushed back forecasts at least temporarily, herd immunity is still possible by mid-year.

Note: Assumes current acceleration of trend, capped at 3mm doses/day, with 50% of doses administered going to >65s. 

EXPECT DEATHS TO PLUMMET
As Vulnerable Population Gets Vaccine

expect deaths to plummet as vulnerable population gets vaccinated

Take Away:

The model suggests deaths are set to fall dramatically in the coming months as vaccinations of seniors (the most vulnerable group) spread.

Note: "Vulnerable" population is estimated Over 65s less estimated Over-65 Cases & Over-65 Vaccinations.

STATES ARE HAVING MIXED VACCINATION RESULTS

states are having mixed vaccine results

Take Away:

No state has distributed at least one dose to less than 11% of their population.

Note: Share first injections as a share of total population.

U.S. National COVID-19 Tracking

TAKE AWAY:
Rapid improvement across metrics continues as deaths start to roll over sharply at a lag.

New Cases

Hospitalization Rate

Death Rate

Stay in the Know

Our COVID-19 Vaccine Tracker Delivered Straight to Your Inbox

Download Your Copy

Download

Share This Page


Information or opinions expressed herein are general and educational in nature and have been provided for information purposes only. Neither the information nor opinions expressed constitute investment or health advice and it is not intended, nor should it be considered, as an endorsement of any specific investment strategy.

The views expressed represent the opinions of Bespoke Investment Group, LLC and are not intended as a forecast or guarantee of future results. Past performance is no guarantee of future results. The information and opinions contained herein are current as of the date published and are subject to change without notice. Information has been obtained from sources believed to be reliable, but its accuracy, completeness, and interpretation are not guaranteed. Bespoke Investment Group, LLC is not affiliated with AMG Funds LLC nor any of its affiliates. Copyright © 2021 Bespoke Investment Group, LLC. All rights reserved. Reproduction and distribution is prohibited without express permission. 

AMG Funds, LLC cannot guarantee that the information herein is accurate, complete, or timely. AMG Funds, LLC makes no warranties with regard to such information or results obtained by its use, and disclaims any liability arising out of your use of, or any reliance on, such information.

© 2021 AMG Funds LLC. All rights reserved. See amgfunds.com for additional disclosures, our privacy policy and terms of use. 

  Back To Top